A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Iradimed Corp stock. As of the latest transaction made, Citadel Advisors LLC holds 1,600 shares of IRMD stock, worth $89,920. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,600
Previous 2,400 33.33%
Holding current value
$89,920
Previous $105,000 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$40.36 - $44.7 $565,161 - $625,934
-14,003 Reduced 44.1%
17,750 $779,000
Q1 2024

May 15, 2024

BUY
$41.17 - $47.29 $474,566 - $545,111
11,527 Added 56.99%
31,753 $1.4 Million
Q4 2023

Feb 14, 2024

BUY
$37.31 - $47.47 $100,550 - $127,931
2,695 Added 15.37%
20,226 $960,000
Q3 2023

Nov 14, 2023

SELL
$43.28 - $50.3 $707,454 - $822,203
-16,346 Reduced 48.25%
17,531 $777,000
Q2 2023

Aug 14, 2023

SELL
$38.88 - $50.61 $714,731 - $930,363
-18,383 Reduced 35.18%
33,877 $1.62 Million
Q1 2023

May 15, 2023

BUY
$28.48 - $42.14 $1.06 Million - $1.56 Million
37,115 Added 245.06%
52,260 $2.06 Million
Q4 2022

Feb 14, 2023

BUY
$26.9 - $30.58 $407,400 - $463,134
15,145 New
15,145 $428,000
Q2 2022

Aug 15, 2022

SELL
$30.15 - $45.79 $169,352 - $257,202
-5,617 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$36.01 - $53.14 $52,898 - $78,062
-1,469 Reduced 20.73%
5,617 $252,000
Q3 2021

Nov 15, 2021

BUY
$29.5 - $37.21 $209,037 - $263,670
7,086 New
7,086 $238,000
Q4 2020

Feb 16, 2021

SELL
$20.62 - $25.0 $260,018 - $315,250
-12,610 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$21.0 - $24.61 $233,478 - $273,613
-11,118 Reduced 46.86%
12,610 $270,000
Q2 2020

Aug 14, 2020

BUY
$18.68 - $24.35 $68,779 - $89,656
3,682 Added 18.37%
23,728 $550,000
Q1 2020

May 15, 2020

BUY
$16.08 - $27.67 $322,339 - $554,672
20,046 New
20,046 $428,000

Others Institutions Holding IRMD

About IRADIMED CORP


  • Ticker IRMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 12,565,100
  • Market Cap $706M
  • Description
  • IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible pati...
More about IRMD
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.